OUR PRODUCTS

MOBILE APPS

GENERAL INFO

ADCT

Stock ticker: NYSE

PRICE

CHANGE

CAPITALIZATION

ADC Therapeutics SA (ADCT) Earnings Date & Reports

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ADCT is expected to report earnings to rise 45.60% to -36 cents per share on November 11

ADC Therapeutics SA ADCT Stock Earnings Reports

Q3'25

Est.

$-0.36

Q2'25

Beat

by $0.14

Q1'25

Beat

by $0.18

Q4'24

Beat

by $0.18

Q3'24

Beat

by $0.10

The last earnings report on August 12 showed earnings per share of -25 cents, beating the estimate of -38 cents. With 500.02K shares outstanding, the current market capitalization sits at 352.12M.

View a ticker or compare two or three

Compare

ADCT

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ADCT
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ADCT showed earnings on August 12, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

Route de la Corniche 3B

Phone

+41 216530200

Employees

274

Web

https://www.adctherapeutics.com